GRK3 and pachyonychia congenita: To our knowledge, our study is the first to report GRK3 expression in a large cohort of GAC patients, consisting of 393 pairs of the primary tumor and non-tumor adjacent tissues, as well as PC cells from metastatic GAC patients.